What happened to Tatva Chintan IPO?
Table of Contents
What happened to Tatva Chintan IPO?
The finalization of Basis of Allotment for Tatva Chintan Pharma IPO will be done on Jul 26, 2021, and the allotted shares will be credited to your demat account by Jul 28, 2021.
How good is Tatva Chintan IPO?
The stock opened at Rs 2,111.80 on the BSE, up 95 percent over the issue price of Rs 1,083. It was trading at Rs 2,304.35, up 112.77 percent, with volumes of 6.38 lakh equity shares at the time of publishing this copy. With more than 100 percent gains, it is one of the strongest listings of 2021.
Should I buy Tatva Chintan Pharma IPO?
The issue is valued at 45.9x FY21 P/E on post issue basis, which appears reasonable compared to peers (avg. P/E of 59x) as it enjoys higher earnings growth (62 per cent CAGR vs avg. 38 per cent CAGR for peers over FY18-21). Hence, we recommend Subscribe,” Motilal Oswal added.
Should we buy Tatva Chintan after listing?
On advice to those who got Tatva Chintan shares allotted; Ravi Singhal of GCL Securities said, “Since, they are getting more than 100 per cent listing gains, I would advise them to book 50 per cent profit, fish out their principal and remain invested in the stock with their listing gains for at least 6-9 months.”
What is the GMP of Tatva Chintan?
The Grey Market Premium (GMP) of Tatva Chintan Pharma Chem was reported as trading at Rs 1,100 over the given issue size, which marks a 100 per cent increase.
What is the issue price of Tatva Chintan?
NEW DELHI: Tatva Chintan Pharma Chem made a solid market debut on Thursday, as the scrip got listed at Rs 2,111.80 on BSE, a 95 per cent premium over its issue price of Rs 1,083. On NSE, the scrip got listed at Rs 2,111.85, up 95 per cent.
Is tatva Chintan a GMP?
Tatva Chintan IPO Listing Date, Tatva Chintan Share Price: Tatva Chintan grey market premium or GMP is currently at Rs 1,100.
What is the GMP of Tatva Chintan Pharma?
Can Tatva Chintan grow?
Tatva Chintan plans to continue to increase offerings in current business segments as well as diversify into new products by tapping into segments, which in the view of the management, have attractive growth prospects. The company is expected to witness strong growth for next 2-3 years given its expansion plans.
Is Tatva Chintan good company?
The company has a good business model and has promoters with good track record, said the Market Guru. “It’s an old company with experienced promoters. Also, the company promises good growth outlook with recent capex. This Rs 500 crore issue will further strengthen Tatva Chintan Pharma Chem Ltd’s capex.
How do you use Tatva Chintan?
Investors can log in to the BSE website to check Tatva Chintan IPO allotment status online.
- You can log in at the direct BSE link bseindia.com/investors/appli_check.aspx.
- After logging in, enter Tatva Chintan Pharma Chem IPO in the issue name.
- You will have then have to enter your application number.
What is GMP of Tatva Chintan Pharma IPO?
The Grey Market Premium (GMP) of Tatva Chintan Pharma Chem was reported as trading at Rs 1,100 over the given issue size, which marks a 100 per cent increase. Tatva Chintan Pharma Chem Ltd is set to make its mark in the public domain as it gets ready for its listing date that is on July 29.